Market Overview

26 Stocks Moving in Tuesday's Pre-Market Session



  • Cidara Therapeutics, Inc. (NASDAQ: CDTX) shares rose 82.1% to $3.06 in pre-market trading after the company announced it has formed a partnership with Mundipharma to develope and commercialize Rezafungin. Cidara will receive an upfront payment of $30 million and an equity investment of $9 million.
  • Ossen Innovation Co., Ltd. (NASDAQ: OSN) shares rose 21% to $4.90 in pre-market trading after gaining 8.00% on Friday.
  • Conn's, Inc. (NASDAQ: CONN) rose 13.1% to $22.79 in pre-market trading as the company reported better-than-expected Q2 earnings.
  • The Medicines Company (NASDAQ: MDCO) rose 11.6% to $46.84 in pre-market trading after the company presented results from its ORION-11 trial at ESC Congress 2019. In the trial, inclisiran met all primary and secondary efficacy endpoints.
  • Zealand Pharma A/S (NASDAQ: ZEAL) rose 10% to $21.10 in pre-market trading. Boehringer Ingelheim and Zealand Pharma announced plans to initiate Phase 2 development of the GLP-1/glucagon dual agonist BI 456906.
  • BioLineRx Ltd. (NASDAQ: BLRX) rose 8.8% to $3.10 in pre-market trading. BioLineRx disclosed that it has successfully completed dose-escalation part of Phase 1/2a clinical study for AGI-134 immunotherapy for the treatment of solid tumors.
  • Napco Security Technologies, Inc. (NASDAQ: NSSC) rose 6.1% to $36.57 in pre-market trading.
  • Eldorado Gold Corporation (NYSE: EGO) rose 5% to $9.64 in pre-market trading.
  • Blue Apron Holdings, Inc. (NYSE: APRN) shares rose 4.7% to $7.10 in pre-market trading.
  • Grupo Supervielle S.A. (NYSE: SUPV) rose 4.5% to $2.57 in pre-market trading after falling 8.55% on Friday.
  • Momo Inc. (NASDAQ: MOMO) rose 3.5% to $38.05 in pre-market trading.
  • Teekay LNG Partners L.P. (NYSE: TGP) rose 5% to $15.25 in pre-market trading.
  • Sturm, Ruger & Company, Inc. (NYSE: RGR) rose 4.9% to $43.00 in pre-market trading.
  • Sanofi SA (NASDAQ: SNY) rose 3.2% to $44.31 in pre-market trading after Bernstein initiated coverage on the company's stock with an Outperform rating and a $52 price target.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers


  • Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares fell 82.6% to $9.22 in pre-market trading.
  • CIM Commercial Trust Corporation (NASDAQ: CMCT) fell 67.6% to $19.44 in pre-market trading.
  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares fell 27.1% to $8.52 in pre-market trading after reporting Phase 2 clinical trial results of AR-105 for the treatment of ventilator-associated pneumonia caused by pseudomonas aeruginosa.
  • Sasol Limited (NYSE: SSL) fell 7.8% to $17.44 in pre-market trading.
  • Intelsat S.A. (NYSE: I) fell 7.2% to $19.20 in pre-market trading.
  • Newell Brands Inc. (NYSE: NWL) shares fell 6.1% to $15.59 in pre-market trading.
  • MoSys, Inc. (NASDAQ: MOSY) fell 6% to $2.50 in the pre-market trading session after rising 5.56% on Friday.
  • Seadrill Limited (NYSE: SDRL) fell 6% to $2.21 in pre-market trading after dropping 6.75% on Friday.
  • Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) fell 5.3% to $3.60 in pre-market trading.
  • Pareteum Corporation (NASDAQ: TEUM) fell 4.2% to $2.05 in the pre-market trading session.
  • Micro Focus International plc (NYSE: MFGP) shares fell 4.2% to $13.22 in pre-market trading after gaining 6.32% on Friday.
  • Mallinckrodt plc (NYSE: MNK) fell 3.5% to $2.50 in pre-market trading after declining 15.91% on Friday.

Related Articles (APRN + ARDS)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at